Lucilia Mouriès, PhD

Cell therapies | Biotechnology | Collaborative Science. EN, FR, PT. Views my own.

[Lucilia Mouriès, PhD @LMouries]

Hard to believe this is already the 7th annual update of COMPARE! We strive to make it better year after year (and document the updates: https://t.co/kdHGXwjwzv). Have a look, explore and let us know what you think!
#allergens, #novelproteins, #novelfoods, #safetyassessment

[HESI @HESI_Global]

The COMPARE 2023 #database is now available! COMPARE is a #transparent resource for identifying #protein #sequences that are known #allergens. Check out the updates at the link below!
https://t.co/IgmzJYIMih

#regulatory #science #allergenicity #riskassessment

[Lucilia Mouriès, PhD @LMouries]

@pedrocarlosalv7 @nytimes Palavras da ESA:

[ESA Operations @esaoperations]

🌠 Fireball update!

It appears that this object was a small piece of a comet.

We estimate that it flew over Spain and Portugal travelling at ~45 km/s before burning up over the Atlantic Ocean at an altitude of ~60 km.

The likelihood of any meteorites being found is very low.

[Lucilia Mouriès, PhD @LMouries]

Stunning meteor seen by family members last night in Portugal, WOW!

[ESA Operations @esaoperations]

🌠 Fireball update!

It appears that this object was a small piece of a comet.

We estimate that it flew over Spain and Portugal travelling at ~45 km/s before burning up over the Atlantic Ocean at an altitude of ~60 km.

The likelihood of any meteorites being found is very low.

[HESI @HESI_Global]

The Protein Allergens, Toxins and Bioinformatics committee seeks partners to launch a project to advance methods for assessing gluten-like peptides that could trigger #celiacdisease. #PATB #organoids #NAMs
Read more here: https://t.co/jcrpR55hMR

[Lucilia Mouriès, PhD @LMouries]

It’s now at 17:00 Paris time!! You don’t want to miss this talk 👍 #ISCT2023 https://t.co/NPzdsTuYYK

[Lucilia Mouriès, PhD @LMouries]

@DrPHanley @ISCT Love the French béret with ISCT colors 😊. Good find! Looking forward ISCT TV highlights.

[HESI @HESI_Global]

Will you be at #ISCT2023 next week? Dr. Mick Fellows of @AstraZeneca and co-chair of CT-TRACS will present developments of the committee project on advanced #sequencing methods for detection of off-target edits in #genomeediting. https://t.co/xo2Iat8WS9

[HESI @HESI_Global]

#HESI and the @US_FDA will be hosting a public virtual workshop May 31 - Jun 1 to engage stakeholders with expertise in the assessment of nitrosamines (NA), including Nitrosamine Drug Substance-related Impurities (NDSRI), for research roadmap planning: https://t.co/eQfZGAnPrP

[HESI @HESI_Global]

Dr. Mick Fellows of @AstraZeneca and co-chair of #HESI CT-TRACS was invited to speak about developments of the committee project on advanced #sequencing methods for detection of off-target edits in #genomeediting at the #ISCT2023 Annual Meeting. https://t.co/xo2Iat8WS9

[HESI @HESI_Global]

#HESI and the @US_FDA will be hosting a public virtual workshop May 31 - Jun 1 to engage stakeholders with expertise in the assessment of nitrosamines (NA), including Nitrosamine Drug Substance-related Impurities (NDSRI), for research roadmap planning: https://t.co/eQfZGAnPrP

[Lucilia Mouriès, PhD @LMouries]

@DvirLab I’ll be there too 😊!

[Lucilia Mouriès, PhD @LMouries]

Last day at #ISBR2023! Learned a lot, met a lot of new people and shared some of our work. Last chance to visit @HESI_Global booth!

[Lucilia Mouriès, PhD @LMouries]

Great to see @HESI_Global’ s #COMPAREdatabase used in real world scenarios. Great presentation by Matthew Pence at #ISBR2023, speaking about intractable proteins.

[Lucilia Mouriès, PhD @LMouries]

Excited to bring the HESI flag to the International Society Biosafety Research Symposium @ISBRSymposium next week in St. Louis, MO, and share the work of the @HESI_Global' Protein Allergens, Toxins and Bioinformatics committee, #HESI_PATB.
#ISBR2023
#bioinnovation #biosafety

[HESI @HESI_Global]

Deadline for submission has been extended to May 7th, 2023! The #HESI #GTTC seeks #graduatestudents and #postdoctoral fellows working in #genetic #toxicology or #genomics for the Spring 2023 Professional Development #award. Apply here https://t.co/lqrz3Swuhd

[Lucilia Mouriès, PhD @LMouries]

Finding robust alternative methods to animal studies for tumorigenicity testing of cell therapy products is a must: this publication is the first of a series on the topic, from HESI CT_TRACS Committee. 👏👏👏

[HESI @HESI_Global]

Results of an international study by HESI’s #CT-TRACS committee indicate that the HEC assay is highly sensitive and robust and can be applicable for tumorigenicity evaluation of hPSC-derived cell therapy products. Link to the full article below.
https://t.co/6CRfjpihMC

[HESI @HESI_Global]

Results of an international study by HESI’s #CT-TRACS committee indicate that the HEC assay is highly sensitive and robust and can be applicable for tumorigenicity evaluation of hPSC-derived cell therapy products. Link to the full article below.
https://t.co/6CRfjpihMC

[HESI @HESI_Global]

Register now for the #HESI 2023 Annual Meeting co-organized with the @NC3Rs in Central London on June 7-8th. This meeting will bring fresh perspectives to the topic of New Approach Methodologies #NAMs for #safetyassessement.
https://t.co/ggeAvBipjE

[Lucilia Mouriès, PhD @LMouries]

Find us, and the many programs presenting talks and sessions, in Nashville at #2023SOT. See you there!

[HESI @HESI_Global]

See you in Nashville! Several HESI Committees will be attending #2023SOT #ToxExpo next week! Check out our lineup and reach out if you want to connect! @SOToxicology #toxicology

https://t.co/Y0jepqbcN2

[Lucilia Mouriès, PhD @LMouries]

It’s today! “Assessment of #CRISPR-Cas9 Induced #OffTarget Mutagenesis in #GeneEdited #CellularTherapeutics (Induce-Seq + DS): A HESI #CT_TRACS Supported Project”.
#ACTOX2022, Symposium 3

[Lucilia Mouriès, PhD @LMouries]

Going to #ACTOX2022 next week? Don’t miss the overview of #CT_TRACS committee's Advanced Sequencing project: “Assessment of CRISPR-Cas9 Induced Off-Target Mutagenesis in Gene-Edited Cellular Therapeutics: A HESI CT-TRACS Supported Project”. Monday Nov. 24th, Symposium 3.